BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/29/2024 6:31:20 AM | Browse: 210 | Download: 899
 |
Received |
|
2024-03-29 14:16 |
|
Peer-Review Started |
|
2024-03-29 14:16 |
|
First Decision by Editorial Office Director |
|
2024-05-03 19:15 |
|
Return for Revision |
|
2024-05-06 03:28 |
|
Revised |
|
2024-05-20 17:56 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-06-21 02:39 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-06-21 07:07 |
|
Articles in Press |
|
2024-06-21 07:07 |
|
Edit the Manuscript by Language Editor |
|
2024-06-25 23:43 |
|
Typeset the Manuscript |
|
2024-07-24 07:54 |
|
Publish the Manuscript Online |
|
2024-08-29 06:31 |
| ISSN |
2220-315x (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Biochemistry & Molecular Biology |
| Manuscript Type |
Retrospective Study |
| Article Title |
SCN1A rs6732655A/T polymorphism: Diagnostic and therapeutic insights for drug-resistant epilepsy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Aroop Viswas, Pradeep K Dabla, Dharmsheel Shrivastav, Swapan Gupta, Manisha Yadav, Subhash Yadav and Bidhan Chandra Koner |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Pradeep K Dabla, MD, Professor, Department of Biochemistry, Govind Ballabh Pant Institute of Postgraduate Medical Education and Research, 1, Jawaharlal Nehru Marg, 64 Khamba Raj Ghat, New Delhi 110002, Delhi, India. pradeep_dabla@yahoo.com |
| Key Words |
Epilepsy; Drug resistance; SCN1A gene; Pro-inflammatory cytokines; Genetic factors |
| Core Tip |
Epilepsy poses a substantial global health burden due to its recurrent seizures, with a subset of patients proving resistant to current treatments, leading to increased mortality and decreased quality of life. Genetic factors, including SCN1A gene variants, and their pro-inflammatory cytokines response [interleukin (IL)-1β, IL-6, and high mobility group box 1 protein (HMGB1)], play crucial roles in drug resistance. This study investigates the correlation between SCN1A gene variants (rs6732655A/T) and drug resistance in epilepsy, confirming higher levels of IL-1β, IL-6, and HMGB1 in drug-resistant cases and suggesting specific genotypes (AA and AT) as potential biomarkers for oxidative stress and neuroinflammation in drug-resistant idiopathic epilepsy. |
| Publish Date |
2024-08-29 06:31 |
| Citation |
Viswas A, Dabla PK, Shrivastav D, Gupta S, Yadav M, Yadav S, Koner BC. SCN1A rs6732655A/T polymorphism: Diagnostic and therapeutic insights for drug-resistant epilepsy. World J Exp Med 2024; 14(3): 94999 |
| URL |
https://www.wjgnet.com/2220-315x/full/v14/i3/94999.htm |
| DOI |
https://dx.doi.org/10.5493/wjem.v14.i3.94999 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
